Abbott, Trinity biotech and Beckman Coulter, Inc are Dominating the Global Urinalysis Market in 2019

Global Urinalysis Market is expected to grow with the CAGR of 7.3% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-urinalysis-market

Global urinalysis market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in global urinalysis market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio. For instance, in December 2019, Sysmex Corporation launched the semi-automated urine chemistry analyzer UC-1000 which is the compact model in the field of urine qualitative analysis in the overseas market. This product will provide a detailed analysis of urine sediment and cells, the UC-1000 will contribute to the advancement of healthcare by providing high-value testing and hence better quality will be benefited for the company in the market

Abott Laboratories is dominating player in global urinalysis market. The other key players existing in the market includes Siemens Healthineers, F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Trinity Biotech, Sysmex Corporation, Quidel Corporation, Bio-Rad Laboratories, Inc., Arkray, Inc., Acon Laboratories, Inc, 77 Elektronika Kft Dirui Industrial Co., Ltd.,Thermo Fisher Scientific, Mindray, Analyticon Biotechnologies Ag, Ekf Diagnostics, Hti Medical Inc. Teco Diagnostics, Tenko Medical System Corp and Wama Diagnostica, among others.

Urinalysis MarketAbbott

The company was founded in 1888 and is headquartered in Illinois, U.S. The company focuses on manufacturing of devices in order to manage chronic pain and diabetes among others. The product categories in which the company deals in are diabetes care, diagnostics, nutrition, point of care and the market focused category is diagnostics.

  • In February 2019, Abbott launched the most sensitive rapid diagnostic test to determine HBsAg 2 for the detection of hepatitis B antigens. This test device uses whole blood, serum and even plasma sample for the detection process. The launch of this lateral flow technology helped the company to enhance its platform for capillary blood collection devices.

The company is dealing across the globe in Asia-Pacific, Greater China, Europe, Middle East and Africa, The Americas. Its subsidiaries are Abbott Bioresearch Center, Inc. (Delaware), Abbott Vascular Inc.(Delaware), Knoll Pharmaceutical Company (New Jersey), Abbott Australasia Pty Ltd (Australia) and Abbott Diagnostics International, Ltd. (Bermuda), among others.

Trinity biotech

The company was founded in 1992 and is headquartered in Bray, Ireland. The major focus of the company is to provide excellence in the developing, manufacturing and marketing of diagnostic products. The product categories in which the company deals in are point of care, infectious diseases, hemoglobin's, autoimmune, clinical chemistry, antibodies & proteins, urinalysis and the market focused category is urinalysis.

  • In March 2017, Trinity Biotech launched a new range of autoimmune laboratory instrumentation for the autoimmune product line. This product will help in taking the testing operations to the next level with a complete range of immunofluorescence (IFA), Enzyme-Linked Immunosorbent Assay (ELISA), and Line Immunoassay (LIA) liquid handling instruments. This will further help the company in expanding its services within the new range.

The company is dealing across the globe in North America, Europe, Asia-Pacific, Middle East and Africa. Its subsidiaries are Immuno Diagnostics (U.S.), Inc, Biopool US Inc. (U.S.), TrINITY Biotech manufacturing Ltd (U.S.) and Fiomi Diagnostic AB (U.S.), among others.

Beckman Coulter, Inc.

The company was founded in 1935 and is headquartered in Pasadena, U.S. The company develops, manufactures the markets products that simplify automate and innovate complex biological testing. The product categories in which the company deals in are chemistry, immunoassays, hematology, urinalysis, microbiology, blood banking, protein chemistry and the market focused category is urinalysis.

  • In May 2019, Backam Coulter, Inc introduced a total laboratory automation solution having a new standard for turnaround time. This automation solution services will help in getting good quality results and will improve laboratory operations. This will help the company in setting a new standard of quality services and hence will help in generating more revenue in the future.

The company is dealing across the globe in North America, South America, Europe, Middle East & Africa & Asia Pacific. Its subsidiaries are Labcyte Inc (U.S.), Beckman Coulter K.K. (U.S.), Beckman Coulter international S.A. (South America) and Beckman coulter Eurocenter S.A. (U.S.), among others.